Hepcidin: Homeostasis and Diseases Related to Iron Metabolism

Abstract

Iron is an essential metal for cell survival that is regulated by the peptide hormone hepcidin. However, its influence on certain diseases is directly related to iron metabolism or secondary to underlying diseases. Genetic alterations influence the serum hepcidin concentration, which can lead to an iron overload in tissues, as observed in haemochromatosis, in which serum hepcidin or defective hepcidin synthesis is observed. Another genetic imbalance of iron is iron-refractory anaemia, in which serum concentrations of hepcidin are increased, precluding the flow and efflux of extra- and intracellular iron. During the pathogenesis of certain diseases, the resulting oxidative stress, as well as the increase in inflammatory cytokines, influences the transcription of the HAMP gene to generate a secondary anaemia due to the increase in the serum concentration of hepcidin. To date, there is no available drug to inhibit or enhance hepcidin transcription, mostly due to the cytotoxicity described in the in vitro models. The proposed therapeutic targets are still in the early stages of clinical trials. Some candidates are promising, such as heparin derivatives and minihepcidins. This review describes the main pathways of systemic and genetic regulation of hepcidin, as well as its influence on the disorders related to iron metabolism.

No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases

“…The protein hepcidin is a key regulator of mammalian iron metabolism (Ganz, ; Ganz & Nemeth, ; Michels et al ., ; Reichert et al ., ; Vyoral & Jiri, ; Zaritsky et al ., ). As Zughaier et al .…”

The Effects of Angelica Sinensis Polysaccharide on Tumor Growth and Iron Metabolism by Regulating Hepcidin in Tumor-Bearing Mice

“…The BMP/SMAD pathway, which mediates hepcidin upregulation by iron and hypoxia was also documented to be critical for hepcidin production, besides the erythropoietic pathway which decreases hepcidin level following an increase in the rate of erythropoiesis [11,20,21]. Cancer stimulates the synthesis of many inflammatory cytokines, including IL-1, IL-6 and TNF-α [41,42].…”

“…Previous studies have revealed that increased serum hepcidin was related to multiple cancers, such as breast cancer, myeloma, renal cell carcinoma and prostate cancer [7][8][9][10]. Hepcidin is homeostatically regulated by iron and erythropoietic activity as well as inflammatory cytokines [9,11]. Hepcidin inhibits iron absorption from the duodenum and iron egress from macrophages and hepatocytes through binding and inducing degradation of iron exporter ferroportin [12,13].…”

Necesidades de investigación para el diagnóstico de anemia en poblaciones de altura

“…Sin embargo, su exceso genera estrés oxidativo, que es también dañino para la función y supervivencia de las células y tejidos. Por ello es importante mantener la homeostasis del hierro (Figura 2) (14,15) . Uno de los mecanismos que utiliza el organismo para mantener la homeostasis del hierro es evitar su excreción; así, las pérdidas por descamación de células entéricas y otras son del nivel de 1 mg diario, que es lo que habría que reponer con la dieta.…”